Efficacy of the Unified Protocol on difficulties with emotional regulation in people with multiple sclerosis and associated depression or anxiety disorder: a randomized controlled trial

Islamic Azad University0 个研究点目标入组 64 人开始时间: 2019年9月26日最近更新: 2022年10月17日

试验速览

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33129298/ results (added 03/11/2020)

•1. Diagnosis of MS for 3 years or more
•2. Fluent in Persian
•3. Aged at least 18 years
•4. Received at least one current diagnostic of a valid depression disorder and an anxiety disorder on Structural Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, fourth edition Axis I Disorders.
•4. Received at least one self-report score outside the cut-off range specified for screening measures for anxiety (using the HADS-A scale) and depression (using the HADS-S scale
•5. Willing to participate in the research
•6. Completed and signed consent form
•7. Medical MS agreement for participation

•1. Co-occurring conditions, including positive diagnosis of schizophrenia, bipolar I or II disorder, pervasive developmental disorder, organic brain syndrome, mental retardation , or current suicidal/homicidal ideation
•2. A prior course of cognitive behavioral treatment during the previous year
•3. Other chronic physical illnesses (such as insulin-dependent diabetes and chemotherapy for cancer)
•4. Pregnancy or lactation
•5. Evidence of current or past schizophrenia, psychosis, or organic mental disorder, bipolar disorder, or organic mental disorder
•6. Drug abuse history or drug dependence, except for nicotine
•7. Absenteeism for more than three sessions

发起方